When entering new markets and new therapeutic areas, we are supported by our licensing activities — which have been a part of our company tradition for several decades. The marketing of our own developed and manufactured medicines in non-strategic markets, i.e. those where we are not present with our own subsidiaries or agencies, is in scope for our license-out activities. In these countries we primarily contract the marketing of our products with leading local pharmaceutical companies. Our products are available in numerous countries, and, due to their excellent quality and competitive pricing, are popular and in demand worldwide.

In order to fulfil the different needs of our customers and to expand our therapeutic areas, licensing has become increasingly important as part of our business policy. Our licensors are globally-renowned pharmaceutical companies — who choose us for marketing their products in our region, thanks to our good reputation and expertise.